Synthetic genomics is a new research area within the field of synthetic biology that uses gene therapy, genetic modification, or genetic fabrication to create a new life form, ie., a life form that does not exist in nature. In addition to using custom-designed base pair series, genomicists believe it may be possible to use genetic codes other than the four base pairs of DNA that compose all DNA today.
Life forms of immediate interest are those that can be used for fuel products or to process undesirable materials such as sequestered carbon.
With today's genetics technologies, it is straight-forward to construct long base pair chains cheaply and accurately. Researchers can then experiment with, or computationally simulate, these new DNA to see what useful purpose the life form might provide. Scientists believe that there will be a large number of commercially viable applications that will re-invent the production of energy, chemicals and pharmaceuticals, and potentially assist with environmental remediation.
Synthetic Genomics Inc. (SG) is a privately-held company with offices in Rockville, Maryland and La Jolla, California. SG is one of the first companies to attempt to develop and commercialize synthetic genomic processes and naturally occurring processes for the production of clean, renewable alternative energy solutions.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment